Associate Professor of Internal diseases №2
Phone: +998903287402
e-mail: nigora1974@mail.ru

EDUCATION:
1991-1997-student of 2 Tashkent medical Institute
1997-1998-Internship in 12 family clinics
1998-2000-General practitioner in 12 family clinics
2000-2002-clinical resident at the Tashkent medical Institute in the endocrinology course

WORK EXPERIENCE

2002-2005-assistant in the course of endocrinology 1 TASHMI
2005-2011-assistant of the Department of training of HEP with endocrinology TMA
2011-2016-senior lecturer of the Department of training of HEP with endocrinology TMA
2016-till present-associate Professor of Internal diseases Department no.2 TMA

Main areas of practical activity

Improving the diagnosis and treatment of endocrine diseases.

Main directions of scientific activity
Development of modern diagnostics and treatment of complications of type 2 diabetes.
Main scientific works for the last 5 years
1. Assessment of the quality of life of patients with type 2 diabetes mellitus complicated by diabetic polyneuropathy / / Medicine #3 2017-p. 49-56.
2. Influence of type 2 diabetes mellitus on the course of nodular goiter of the thyroid gland in older age group / / Young scientist no. 20 2017-p. 203-205.
3. Evaluation of erectile dysfunction in older patients with nodular goiter of the thyroid gland. // XII Congress “Men’s health” collection of abstracts June 16-18, 2016.
4. Clinical features of the course of diffuse toxic goiter in men // Neurology #4, 2017 Pages 21-23
5. Endocrine aspects of pituitary microadenomas / / Fundamental and applied scientific research: current issues, achievements and innovations, part 1, 2018, pp. 180-186.
6. Sitagliptin in the treatment of patients with diabetes 2 nd type concomitant chronic renal disease / / European research: innovation in science, education and technology, -2019. – p. 54-58.
7. Sibutramine in the treatment of obesity in women / / European research: innovation in science, education and technology, -2019. – p. 58-61
8. features of the course of coronary heart disease in patients with type 2 diabetes mellitus // Tibbietdagi innovatsiyalar: esh olimlar Nazari, Tashkent, -2018. – p. 353.
9. features of the course of coronary heart disease in patients with type 2 diabetes mellitus // Bulletin of the South Kazakhstan medical Academy, No. 1, 2019, p. 119.
10. use of sibutramine in the treatment of obesity in women // Bulletin of the South Kazakhstan medical Academy, No. 1, 2019, p. 117.
11. Features of the course of subclinical coronary atherosclerosis in patients with type 2 diabetes mellitus // Internauka scientific journal, no. 13, 2019. – p. 18-21.
12. State of intestinal microbiocenosis in patients with type 2 diabetes mellitus in decompensation and compensation / / Innovative development: potential of science and modern education-2018. – pp. 222-227.
13. Effect of vitamin D on development and duration of type 2 diabetes mellitus / / Neurology # 3, 2018. Pp. 53-55.
14. the Use of sibutramine in the treatment of obesity in women / / Internauka scientific journal, no. 47, 2018. – p. 37-40.
15. Sitagliptin in the treatment of patients with type 2 diabetes and chronic kidney disease // Internauka scientific journal, no. 47, 2018. – pp. 46-49.